Product image of Mydocalm (Tolperisone Hydrochloride) supplied by GNH India

Mydocalm

Active Ingredient:
Tolperisone Hydrochloride
Origin:
EU

Mydocalm (Tolperisone Hydrochloride)

Tolperisone, the active ingredient in Mydocalm, is a centrally acting skeletal muscle relaxant presented as an oral tablet for oral use. It is employed to relieve muscle spasm, musculoskeletal pain, low back pain and cervical pain in adult patients.
GNH India supplies Mydocalm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Gedeon Richter Plc.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Mydocalm (tolperisone) acts on the central nervous system to reduce muscle hypertonia and is indicated for several musculoskeletal conditions.

  • Muscle spasm: alleviates involuntary muscle contraction and associated discomfort.
  • Low back pain: reduces pain and improves functional mobility in lumbar region.
  • Cervical pain: eases neck muscle tension and pain.
  • Musculoskeletal pain: diminishes general skeletal muscle discomfort.

How It Works

  • Tolperisone blocks voltage‑gated sodium channels in the spinal cord, which dampens neuronal excitability and reduces reflex muscle hypertonia. By inhibiting these channels, it decreases the transmission of spasm‑inducing signals, leading to relaxation of skeletal muscles without significant impact on voluntary motor function.

Side Effects

Tolperisone is generally well tolerated, but adverse reactions can occur.

Common Side Effects

  • Dizziness: sensation of light‑headedness or unsteadiness.
  • Drowsiness: increased sleepiness, especially after initial dosing.
  • Nausea: mild gastrointestinal upset.
  • Headache: transient cranial discomfort.
  • Dry mouth: reduced salivary flow.
  • Hypotension: mild lowering of blood pressure.

Serious or Rare Side Effects

  • Severe skin reactions: such as Stevens‑Johnson syndrome.
  • Anaphylaxis: acute allergic response with breathing difficulty.
  • Blood dyscrasias: including agranulocytosis or leukopenia.
  • Hepatic enzyme elevation: abnormal liver function tests.
  • Cardiac arrhythmia: irregular heart rhythm.
  • Persistent hypotension: marked drop in blood pressure requiring medical attention.

Precautions & Warnings

When prescribing Mydocalm, clinicians should consider several safety aspects.

  • Renal impairment: use with caution and monitor renal function.
  • Hepatic impairment: adjust therapy if liver disease is present.
  • Elderly patients: start at lower dose and observe for increased sensitivity.
  • Concomitant CNS depressants: may enhance drowsiness or dizziness.
  • Driving and machinery: advise patients to avoid operating vehicles until they know how the drug affects them.
  • Store at ambient temperature: keep below 25 °C, in the original packaging, protected from moisture.

Avoid Interactions

Tolperisone may interact with other medications, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid)

  • Other centrally acting muscle relaxants: additive muscle relaxation and sedation.
  • CNS depressants (e.g., benzodiazepines, opioids): increased risk of profound drowsiness.
  • Alcohol: may potentiate sedative effects.

Moderate Interactions (Monitor Closely)

  • Antihypertensive agents: possible additive blood pressure lowering.
  • Antihistamines: may enhance drowsiness.
  • CYP450 inhibitors: could raise tolperisone plasma levels, requiring dose adjustment.

Frequently Asked Questions

Mydocalm, containing tolperisone, is prescribed to manage muscle spasm, low back pain, cervical pain and general musculoskeletal discomfort. It helps relax skeletal muscles by reducing abnormal reflex activity, thereby improving mobility and reducing pain in affected areas.

Tolperisone blocks voltage‑gated sodium channels in the spinal cord, which lowers neuronal excitability and diminishes reflex muscle hypertonia. This action reduces the transmission of spasm‑inducing signals, leading to muscle relaxation without significantly affecting voluntary movement.

The appropriate dose of Mydocalm is determined by the prescribing healthcare professional based on the patient’s condition, age, renal and hepatic function, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for tolperisone in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision should be made by a qualified healthcare provider after careful evaluation.

To place an order, submit an enquiry on the Mydocalm product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with other centrally acting muscle relaxants, tolperisone has a distinct mechanism that blocks spinal sodium channels rather than acting on GABA receptors. This may result in a lower incidence of certain side effects such as strong sedation, but individual response varies and choice of therapy should be individualized.

Mydocalm should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in their original packaging, protect them from moisture and direct sunlight, and ensure they are out of reach of children.

Mydocalm is taken orally, usually with or without food as directed by the prescriber. The tablets should be swallowed whole with a glass of water and not chewed or crushed unless specifically instructed.

Serious risks, though rare, include severe skin reactions such as Stevens‑Johnson syndrome, anaphylactic allergic responses, blood dyscrasias like agranulocytosis, significant hypotension, and cardiac arrhythmias. Patients should seek immediate medical attention if they experience any of these symptoms.

Mydocalm is contraindicated in patients with known hypersensitivity to tolperisone or any excipients in the formulation. Caution is also advised for individuals with severe hepatic or renal impairment, uncontrolled hypertension, or those taking interacting CNS depressants without medical supervision.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.